Amplification of chromosomal segment 4q12 in non-small cell lung cancer

Alex H. Ramos, Amit Dutt, Craig Mermel, Sven Perner, Jeonghee Cho, Christopher J. Lafargue, Laura A. Johnson, Ann Cathrin Stiedl, Kumiko E. Tanaka, Adam J. Bass, Jordi Barretina, Barbara A. Weir, Rameen Beroukhim, Roman K. Thomas, John D. Minna, Lucian R. Chirieac, Neal I. Lindeman, Thomas Giordano, David G. Beer, Patrick WagnerIgnacio I. Wistuba, Mark A. Rubin, Matthew Meyerson

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

In cancer, proto-oncogenes are often altered by genomic amplification. Here we report recurrent focal amplifications of chromosomal segment 4q12 overlapping the proto-oncogenes PDGFRA and KIT in non-small cell lung cancer (NSCscLCc). Ssingle nucleotide polymorphism (SNP) array and fluorescent in situ hybridization (FISH) analysis indicate that 4q12 is amplified in 3-7% of lung adenocarcinomas and 8-10% of lung squamous cell carcinomas. In addition, we demonstrate that the NSCLC cell line NCI-H1703 exhibits focal amplification of PDGFRA and is dependent on PDGFR? activity for cell growth. Treatment of NCI-H1703 cells with PDGFRA-specific shRNAs or with the PDGFR?/KIT small molecule inhibitors imatinib or sunitinib leads to cell growth inhibition. However, these observations do not extend to NSCLC cell lines with lower-amplitude and broader gains of chromosome 4q. Together these observations implicate PDGFRA and KIT as potential oncogenes in NSCLC, but further study is needed to define the specific characteristics of those tumors that could respond to PDGFR?/KIT inhibitors.

Original languageEnglish (US)
Pages (from-to)2042-2050
Number of pages9
JournalCancer Biology and Therapy
Volume8
Issue number21
StatePublished - Nov 1 2009

Fingerprint

Non-Small Cell Lung Carcinoma
Proto-Oncogenes
Cell Line
Growth
Fluorescence In Situ Hybridization
Oncogenes
Squamous Cell Carcinoma
Neoplasms
Nucleotides
Chromosomes
Lung
Imatinib Mesylate
sunitinib
Adenocarcinoma of lung

Keywords

  • 4q12
  • Amplification
  • Imatinib
  • KIT
  • Lung cancer
  • NSCLC
  • PDGFRA
  • Sunitinib

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Molecular Medicine
  • Pharmacology

Cite this

Ramos, A. H., Dutt, A., Mermel, C., Perner, S., Cho, J., Lafargue, C. J., ... Meyerson, M. (2009). Amplification of chromosomal segment 4q12 in non-small cell lung cancer. Cancer Biology and Therapy, 8(21), 2042-2050.

Amplification of chromosomal segment 4q12 in non-small cell lung cancer. / Ramos, Alex H.; Dutt, Amit; Mermel, Craig; Perner, Sven; Cho, Jeonghee; Lafargue, Christopher J.; Johnson, Laura A.; Stiedl, Ann Cathrin; Tanaka, Kumiko E.; Bass, Adam J.; Barretina, Jordi; Weir, Barbara A.; Beroukhim, Rameen; Thomas, Roman K.; Minna, John D.; Chirieac, Lucian R.; Lindeman, Neal I.; Giordano, Thomas; Beer, David G.; Wagner, Patrick; Wistuba, Ignacio I.; Rubin, Mark A.; Meyerson, Matthew.

In: Cancer Biology and Therapy, Vol. 8, No. 21, 01.11.2009, p. 2042-2050.

Research output: Contribution to journalArticle

Ramos, AH, Dutt, A, Mermel, C, Perner, S, Cho, J, Lafargue, CJ, Johnson, LA, Stiedl, AC, Tanaka, KE, Bass, AJ, Barretina, J, Weir, BA, Beroukhim, R, Thomas, RK, Minna, JD, Chirieac, LR, Lindeman, NI, Giordano, T, Beer, DG, Wagner, P, Wistuba, II, Rubin, MA & Meyerson, M 2009, 'Amplification of chromosomal segment 4q12 in non-small cell lung cancer', Cancer Biology and Therapy, vol. 8, no. 21, pp. 2042-2050.
Ramos AH, Dutt A, Mermel C, Perner S, Cho J, Lafargue CJ et al. Amplification of chromosomal segment 4q12 in non-small cell lung cancer. Cancer Biology and Therapy. 2009 Nov 1;8(21):2042-2050.
Ramos, Alex H. ; Dutt, Amit ; Mermel, Craig ; Perner, Sven ; Cho, Jeonghee ; Lafargue, Christopher J. ; Johnson, Laura A. ; Stiedl, Ann Cathrin ; Tanaka, Kumiko E. ; Bass, Adam J. ; Barretina, Jordi ; Weir, Barbara A. ; Beroukhim, Rameen ; Thomas, Roman K. ; Minna, John D. ; Chirieac, Lucian R. ; Lindeman, Neal I. ; Giordano, Thomas ; Beer, David G. ; Wagner, Patrick ; Wistuba, Ignacio I. ; Rubin, Mark A. ; Meyerson, Matthew. / Amplification of chromosomal segment 4q12 in non-small cell lung cancer. In: Cancer Biology and Therapy. 2009 ; Vol. 8, No. 21. pp. 2042-2050.
@article{a311e05902044c5ca5db0d739bdfdfd3,
title = "Amplification of chromosomal segment 4q12 in non-small cell lung cancer",
abstract = "In cancer, proto-oncogenes are often altered by genomic amplification. Here we report recurrent focal amplifications of chromosomal segment 4q12 overlapping the proto-oncogenes PDGFRA and KIT in non-small cell lung cancer (NSCscLCc). Ssingle nucleotide polymorphism (SNP) array and fluorescent in situ hybridization (FISH) analysis indicate that 4q12 is amplified in 3-7{\%} of lung adenocarcinomas and 8-10{\%} of lung squamous cell carcinomas. In addition, we demonstrate that the NSCLC cell line NCI-H1703 exhibits focal amplification of PDGFRA and is dependent on PDGFR? activity for cell growth. Treatment of NCI-H1703 cells with PDGFRA-specific shRNAs or with the PDGFR?/KIT small molecule inhibitors imatinib or sunitinib leads to cell growth inhibition. However, these observations do not extend to NSCLC cell lines with lower-amplitude and broader gains of chromosome 4q. Together these observations implicate PDGFRA and KIT as potential oncogenes in NSCLC, but further study is needed to define the specific characteristics of those tumors that could respond to PDGFR?/KIT inhibitors.",
keywords = "4q12, Amplification, Imatinib, KIT, Lung cancer, NSCLC, PDGFRA, Sunitinib",
author = "Ramos, {Alex H.} and Amit Dutt and Craig Mermel and Sven Perner and Jeonghee Cho and Lafargue, {Christopher J.} and Johnson, {Laura A.} and Stiedl, {Ann Cathrin} and Tanaka, {Kumiko E.} and Bass, {Adam J.} and Jordi Barretina and Weir, {Barbara A.} and Rameen Beroukhim and Thomas, {Roman K.} and Minna, {John D.} and Chirieac, {Lucian R.} and Lindeman, {Neal I.} and Thomas Giordano and Beer, {David G.} and Patrick Wagner and Wistuba, {Ignacio I.} and Rubin, {Mark A.} and Matthew Meyerson",
year = "2009",
month = "11",
day = "1",
language = "English (US)",
volume = "8",
pages = "2042--2050",
journal = "Cancer Biology and Therapy",
issn = "1538-4047",
publisher = "Landes Bioscience",
number = "21",

}

TY - JOUR

T1 - Amplification of chromosomal segment 4q12 in non-small cell lung cancer

AU - Ramos, Alex H.

AU - Dutt, Amit

AU - Mermel, Craig

AU - Perner, Sven

AU - Cho, Jeonghee

AU - Lafargue, Christopher J.

AU - Johnson, Laura A.

AU - Stiedl, Ann Cathrin

AU - Tanaka, Kumiko E.

AU - Bass, Adam J.

AU - Barretina, Jordi

AU - Weir, Barbara A.

AU - Beroukhim, Rameen

AU - Thomas, Roman K.

AU - Minna, John D.

AU - Chirieac, Lucian R.

AU - Lindeman, Neal I.

AU - Giordano, Thomas

AU - Beer, David G.

AU - Wagner, Patrick

AU - Wistuba, Ignacio I.

AU - Rubin, Mark A.

AU - Meyerson, Matthew

PY - 2009/11/1

Y1 - 2009/11/1

N2 - In cancer, proto-oncogenes are often altered by genomic amplification. Here we report recurrent focal amplifications of chromosomal segment 4q12 overlapping the proto-oncogenes PDGFRA and KIT in non-small cell lung cancer (NSCscLCc). Ssingle nucleotide polymorphism (SNP) array and fluorescent in situ hybridization (FISH) analysis indicate that 4q12 is amplified in 3-7% of lung adenocarcinomas and 8-10% of lung squamous cell carcinomas. In addition, we demonstrate that the NSCLC cell line NCI-H1703 exhibits focal amplification of PDGFRA and is dependent on PDGFR? activity for cell growth. Treatment of NCI-H1703 cells with PDGFRA-specific shRNAs or with the PDGFR?/KIT small molecule inhibitors imatinib or sunitinib leads to cell growth inhibition. However, these observations do not extend to NSCLC cell lines with lower-amplitude and broader gains of chromosome 4q. Together these observations implicate PDGFRA and KIT as potential oncogenes in NSCLC, but further study is needed to define the specific characteristics of those tumors that could respond to PDGFR?/KIT inhibitors.

AB - In cancer, proto-oncogenes are often altered by genomic amplification. Here we report recurrent focal amplifications of chromosomal segment 4q12 overlapping the proto-oncogenes PDGFRA and KIT in non-small cell lung cancer (NSCscLCc). Ssingle nucleotide polymorphism (SNP) array and fluorescent in situ hybridization (FISH) analysis indicate that 4q12 is amplified in 3-7% of lung adenocarcinomas and 8-10% of lung squamous cell carcinomas. In addition, we demonstrate that the NSCLC cell line NCI-H1703 exhibits focal amplification of PDGFRA and is dependent on PDGFR? activity for cell growth. Treatment of NCI-H1703 cells with PDGFRA-specific shRNAs or with the PDGFR?/KIT small molecule inhibitors imatinib or sunitinib leads to cell growth inhibition. However, these observations do not extend to NSCLC cell lines with lower-amplitude and broader gains of chromosome 4q. Together these observations implicate PDGFRA and KIT as potential oncogenes in NSCLC, but further study is needed to define the specific characteristics of those tumors that could respond to PDGFR?/KIT inhibitors.

KW - 4q12

KW - Amplification

KW - Imatinib

KW - KIT

KW - Lung cancer

KW - NSCLC

KW - PDGFRA

KW - Sunitinib

UR - http://www.scopus.com/inward/record.url?scp=73549108711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73549108711&partnerID=8YFLogxK

M3 - Article

C2 - 19755855

AN - SCOPUS:73549108711

VL - 8

SP - 2042

EP - 2050

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

SN - 1538-4047

IS - 21

ER -